XML 68 R35.htm IDEA: XBRL DOCUMENT v3.25.0.1
Stock-based Compensation (Tables)
12 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of stock-based compensation expense

Stock‑based compensation expense is included in the consolidated statements of income as follows:

 

 

 

Year Ended December 31,

 

(In thousands)

 

2024

 

 

2023

 

 

2022

 

Selling, general and administrative

 

$

6,040

 

 

$

4,645

 

 

$

5,305

 

Research and development

 

 

334

 

 

 

1,192

 

 

 

2,042

 

Total

 

$

6,374

 

 

$

5,837

 

 

$

7,347

 

Schedule of stock-based compensation expense included in the consolidated statements of operations by award type

Stock‑based compensation expense included in the consolidated statements of income by award type is as follows:

 

 

 

Year Ended December 31,

 

(In thousands)

 

2024

 

 

2023

 

 

2022

 

Stock options

 

$

2,738

 

 

$

1,980

 

 

$

3,057

 

RSUs

 

 

3,348

 

 

 

3,663

 

 

 

4,053

 

RSAs

 

 

123

 

 

 

168

 

 

 

194

 

ESPP

 

 

165

 

 

 

26

 

 

 

43

 

Total stock-based compensation expense

 

$

6,374

 

 

$

5,837

 

 

$

7,347

 

 

Schedule of unrecognized stock-based compensation cost

As of December 31, 2024, the unrecognized stock-based compensation cost and the estimated weighted-average amortization period were as follows:

 

(In thousands)

 

Unrecognized Compensation Cost

 

 

Weighted-Average Amortization Period (Years)

 

Stock options

 

$

6,765

 

 

 

2.8

 

RSUs

 

 

6,996

 

 

 

2.5

 

RSAs

 

 

98

 

 

 

1.3

 

Total unrecognized compensation expense

 

$

13,859

 

 

 

 

Summary of equity award activity and related information

The following table summarizes equity award activity under the 2012 Plan and prior plans and related information:

 

(In thousands, except per share data)

 

Number of outstanding options

 

 

Weighted-Average Exercise Price of Outstanding Options

 

 

Number of outstanding RSUs

 

 

Weighted-Average Fair Value per Share at Grant

 

 

Number of outstanding RSAs

 

 

Weighted-Average Fair Value per Share at Grant

 

Balance as of December 31, 2023

 

 

1,499

 

 

$

14.09

 

 

 

482

 

 

$

12.62

 

 

 

16

 

 

$

14.93

 

Granted

 

 

1,062

 

 

$

16.67

 

 

 

502

 

 

$

15.77

 

 

 

 

 

$

 

Exercised

 

 

(80

)

 

$

12.88

 

 

 

 

 

$

 

 

 

 

 

$

 

Released RSUs and RSAs

 

 

 

 

$

 

 

 

(241

)

 

$

12.52

 

 

 

(9

)

 

$

14.46

 

Forfeited

 

 

(414

)

 

$

15.24

 

 

 

(145

)

 

$

13.86

 

 

 

 

 

$

 

Balance as of December 31, 2024

 

 

2,067

 

 

$

15.23

 

 

 

598

 

 

$

15.00

 

 

 

7

 

 

$

15.50

 

Vested and expected to vest
   as of December 31, 2024

 

 

2,067

 

 

$

15.23

 

 

 

598

 

 

$

15.00

 

 

 

 

 

$

 

 

Summary of weighted-average assumptions used to calculate estimated value of stock options

Black-Scholes-Merton weighted-average assumptions used in calculating the estimated value of stock options granted by Innoviva on the dates of grant were as follows:

 

 

 

Year Ended December 31,

 

 

 

2024

 

 

2023

 

 

2022

 

Risk-free interest rate

 

 

4.2

%

 

 

4.0

%

 

 

3.6

%

Expected term (in years)

 

 

6.10

 

 

 

6.09

 

 

 

6.04

 

Volatility

 

 

35.5

%

 

 

37.8

%

 

 

38.6

%

Dividend yield

 

 

0.0

%

 

 

0.0

%

 

 

0.0

%

Weighted-average estimated fair value of stock options granted

 

$

8.17

 

 

$

5.57

 

 

$

6.43